NetworkNewsBreaks – Endonovo Therapeutics Inc.
Post# of 416
(Total Views: 970)
Posted On: 11/06/2019 3:01:53 PM
NetworkNewsBreaks – Endonovo Therapeutics Inc.’s (ENDV) SofPulse(R) Reduces Opioid Prescriptions at New Hanover Regional Medical Center
Commercial-stage developer of innovative medical devices Endonovo Therapeutics (OTCQB: ENDV) was recently featured in a Wect.com article by Jack Bailey titled, ‘Medical device lowers opioid prescriptions at NHRMC’. The article highlights ENDV’s noninvasive Electroceutical(R) therapeutic device, SofPulse(R). According to the article, surgeons at New Hanover Regional Medical Center are utilizing SofPulse(R) as an alternative to narcotics to treat patients’ pain. SofPulse(R) works by using electromagnetic waves to lower inflammation and accelerate the recovery process. NHRMC urologist Dr. Roc McCarthy pointed out there has been a 30%-40% decline in post-op narcotic prescriptions since they began using the device six months ago. “It’s just opening the door to a world of opportunity for people to come up and innovate other ways of decreasing the amount of pain that people are having,” Dr. Roc McCarthy stated in the article.
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Commercial-stage developer of innovative medical devices Endonovo Therapeutics (OTCQB: ENDV) was recently featured in a Wect.com article by Jack Bailey titled, ‘Medical device lowers opioid prescriptions at NHRMC’. The article highlights ENDV’s noninvasive Electroceutical(R) therapeutic device, SofPulse(R). According to the article, surgeons at New Hanover Regional Medical Center are utilizing SofPulse(R) as an alternative to narcotics to treat patients’ pain. SofPulse(R) works by using electromagnetic waves to lower inflammation and accelerate the recovery process. NHRMC urologist Dr. Roc McCarthy pointed out there has been a 30%-40% decline in post-op narcotic prescriptions since they began using the device six months ago. “It’s just opening the door to a world of opportunity for people to come up and innovate other ways of decreasing the amount of pain that people are having,” Dr. Roc McCarthy stated in the article.
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)Endonovo Therapeutics, Inc. (ENDV) Stock Research Links
Scroll down for more posts ▼